Form 4 Filing for Mineralys Therapeutics, Inc.

This filing details transactions by Warren Eric, Chief Commercial Officer of Mineralys Therapeutics, Inc. (MLYS), on July 21, 2026. Eric acquired 7,438 shares of Common Stock via the exercise of a Stock Option, with the option vesting details noted in footnote 3. He then sold 7,438 shares of Common Stock at a weighted-average price between $26.53 and $27.09, as per footnote 2. These transactions were executed under a Rule 10b5-1 stock selling plan. Post-transaction, Eric holds 45,838 shares directly and has exercised options resulting in 245,438 shares held. The filing was signed by Adam Levy as Attorney-in-fact on July 23, 2026.